Sign in
4

Changes in Ownership

Bolt Biotherapeutics, Inc. Filed Acc 0001209191-21-008753

Director sold 62 shares at $20.00 ($1,240)

  • Director acquired 17,711 shares (option exercise)
  • Director acquired 1,416,352 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

SHAH MAHENDRA · Director

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-02-09 Conversion : show line 1 in the form +944,056 958,341 I
2021-02-09 Conversion : show line 2 in the form +472,296 1,430,637 I
2021-02-09 Option exercise : show line 3 in the form +17,711 $0.07 $1,240 1,448,348 I
2021-02-09 Sale : show line 4 in the form −62 $20.00 $1,240 1,448,286 I
Open-market sales · 62 sh · avg $20.00 · $1,240

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2021-02-09 Conversion : show line 5 in the form Series A- 1 Preferred Stock −944,056 0 I
2021-02-09 Conversion : show line 6 in the form Series B Preferred Stock −472,296 0 I
2021-02-09 Option exercise : show line 7 in the form Warrant (Right to Buy) −17,711 0 I
Loading xslF345X03/doc4.xml…